FOLH1 and neoplasm: This observation was in line with previous findings for [177Lu]Lu-PSMA-ALB-56 and [177Lu]Lu-PSMA-ALB-53, two prostate-specific membrane antigen-targeting ligands, of which the former showed a faster tumor accumulation than the latter because of weaker albumin-binding properties [31].